Godavari Drugs Limited (BOM:530317)
84.88
-1.78 (-2.05%)
At close: Oct 27, 2025
Godavari Drugs Revenue
Godavari Drugs had revenue of 238.24M INR in the quarter ending June 30, 2025, a decrease of -27.75%. This brings the company's revenue in the last twelve months to 1.05B, down -31.89% year-over-year. In the fiscal year ending March 31, 2025, Godavari Drugs had annual revenue of 1.14B, down -27.42%.
Revenue (ttm)
1.05B
Revenue Growth
-31.89%
P/S Ratio
0.61
Revenue / Employee
9.92M
Employees
106
Market Cap
639.19M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 1.14B | -431.17M | -27.42% |
| Mar 31, 2024 | 1.57B | -24.03M | -1.51% |
| Mar 31, 2023 | 1.60B | -16.37M | -1.01% |
| Mar 31, 2022 | 1.61B | 384.48M | 31.31% |
| Mar 31, 2021 | 1.23B | 270.62M | 28.26% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Reliance Industries | 10.00T |
| Life Insurance Corporation of India | 9.04T |
| State Bank of India | 3.50T |
| Larsen & Toubro | 2.69T |
| HDFC Bank | 2.68T |
| Tata Consultancy Services | 2.58T |
| ICICI Bank | 1.91T |
| Bharti Airtel | 1.84T |